Isoniazid and Carbamazepine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isoniazid (isoniazid) and Carbamazepine (carbamazepine). Common drug interactions include tuberculosis skin test positive among females and hyponatraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Isoniazid and Carbamazepine. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Isoniazid?

Isoniazid has active ingredients of isoniazid. It is often used in tuberculosis. eHealthMe is studying from 20,174 Isoniazid users. Check the latest studies of Isoniazid.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 44,628 Carbamazepine users. Check the latest studies of Carbamazepine.



On Jul, 10, 2026

56 people who take Isoniazid and Carbamazepine together, and have interactions are studied.

Isoniazid and Carbamazepine drug interactions.

What are the common drug interactions of Isoniazid and Carbamazepine, by gender? *:

female:

  1. Tuberculosis skin test positive
  2. Viiith nerve lesion
  3. Weakness
  4. White blood cell count decreased
  5. Dizziness
  6. Gait disturbance
  7. Ataxia (loss of full control of bodily movements)
  8. Confusional state
  9. Drug level above therapeutic
  10. Febrile neutropenia (fever with reduced white blood cells)

male:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Pyrexia (fever)
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Vomiting
  5. Abasia (inability to walk)
  6. Abdominal pain upper
  7. Anticonvulsant drug level above therapeutic
  8. Arthralgia (joint pain)
  9. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  10. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)

What are the common drug interactions of Isoniazid and Carbamazepine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

10-19:

  1. Hepatic failure (liver failure)
  2. Asterixis (flapping tremor, or liver flap)
  3. Depressed level of consciousness
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Acute hepatic failure
  8. Anticonvulsant drug level above therapeutic
  9. Coagulation factor v level decreased
  10. Drug ineffective

20-29:

  1. Eating disorder
  2. Delusion (a false belief or opinion)
  3. Hallucination (an experience involving the perception of something not present)
  4. Influenza
  5. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  6. Nausea (feeling of having an urge to vomit)
  7. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  8. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  9. Tachypnoea (a condition of rapid breathing over 20 per minute)
  10. Abasia (inability to walk)

30-39:

  1. Dehydration (dryness resulting from the removal of water)
  2. Fatigue (feeling of tiredness)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Abdominal pain upper
  5. Asthenia (weakness)
  6. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  7. Cough
  8. Difficulty in walking
  9. Eye pain
  10. Headache (pain in head)

40-49:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Water intoxication (water poisoning)
  3. Dizziness
  4. Asthenia (weakness)
  5. Gastrointestinal perforation (hole in the digestive tract)
  6. Hypomania (a mild form of mania, marked by elation and hyperactivity)
  7. Large intestine perforation (hole in large intestine)
  8. Bipolar affective disorder
  9. Lethargy (tiredness)
  10. Muscle spasms (muscle contraction)

50-59:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Confusional state
  3. Drug level above therapeutic
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Gait disturbance
  6. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Hypovolaemia (a decreased volume of circulating blood in the body)
  9. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  10. Mucosal inflammation (infection of mucous membrane)

60+:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Acute hepatic failure
  3. Arthralgia (joint pain)
  4. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  5. Constipation
  6. Erythrodermic psoriasis (generalized redness of the skin)
  7. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  8. Pneumonia
  9. Skin lesion

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 16.07%
  2. Pain: 6 people, 10.71%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 8.93%
  4. High Blood Pressure: 5 people, 8.93%
  5. Oedema (fluid collection in tissue): 4 people, 7.14%
  6. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 7.14%
  7. Dyspnea (difficult or laboured breathing): 4 people, 7.14%
  8. Psychotic Disorder: 3 people, 5.36%
  9. Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.36%
  10. Hiv Infection: 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Isoniazid and Carbamazepine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isoniazid and Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isoniazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isoniazid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbamazepine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on isoniazid and carbamazepine (the active ingredients of Isoniazid and Carbamazepine, respectively), and Isoniazid and Carbamazepine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: